25th January 2023 | Mumbai | Investment Banking
Avendus Capital, India’s largest Investment Banking franchise, launched a thought paper on India’s Retail Health
Insurance market today. According to the study, the Retail Health Insurance segment has the potential to become a
USD 25 billion market in the next five years. It also found that Standalone Health Insurers (SAHIs), that predominantly
focus on the Retail Health segment, have disrupted the market to capture 50%+ market share and are expected to
be the biggest beneficiaries of growth within the segment.
The Health Insurance sector in India has disrupted the insurance market growing at a rapid pace to become the largest
non-life insurance segment in FY22. With c.45% of India’s relevant population devoid of any health coverage, this
segment is expected to be the leader among other non-life segments. Low penetration (with only 60 million individuals
covered), coupled with COVID led rise in awareness, product innovation, rising disposable income etc. are some of the
key catalysts for growth in the Retail Health segment, where coverage is expected to reach c.250 million individuals,
leading to keen investor interest over the past few years.
Over the years, significant regulatory steps have been taken to attract participation from foreign investors and SAHIs
have seen investments from marquee Domestic and Global PEs. The study points out that the Retail Health segment
is expected to witness continued investor interest backed by multiple growth tailwinds and offer the ability to generate
RoE (return on equity) of 20%+ in a steady state.
Unveiling the report, Anshul Agarwal, Managing Director and Co-head, Consumer, Financial Institutions Group (FIG) &
Business Services, Avendus Capital said, “Retail Health Insurance will continue to be one of the most exciting
segments within the overall Non-Life Insurance space. Its unique characteristics such as high persistency of c.90%,
pricing power, relatively low loss ratio and headroom for growth due to low penetration would see significant
investments being done in this space to capture incremental market share. We believe that the segment has the
potential to catapult to USD 25 billion in next five years. In addition to this, the ability to generate consistently high
profits and RoE of 20%+ would account for sustained investor appetite due to limited opportunities in companies
which focus purely on the Retail Health segment.”
On SAHI’s prospects, Snigdha Khemka, Director, Consumer, Financial Institutions Group (FIG) & Business Services,
Avendus Capital said, “SAHIs have established a dominant presence in the retail health segment. Awareness of health
insurance post-COVID has acted as a strong catalyst. Given that the distribution of Retail Health is primarily individual
agent driven, SAHIs’ single product focus and distribution arbitrage over multi-line insurers provide them with a
significant competitive advantage. We believe that, in the near future, Insurers will continue their focus on product
innovation centred around holistic wellbeing to maximize customer lifetime value.”
Click here to download the report
About Avendus
Avendus Group is a leading financial services firm with a presence in the areas of Investment Banking, Institutional
Equities, Wealth Management, Credit Solutions and Asset Management. Established in 1999 in Mumbai, India,
Avendus is today present in 11 cities across India, the US, UK and Singapore. Avendus partners with the Indian
entrepreneur ecosystem to provide differentiated solutions that enable clients to meet their strategic aspirations.
Avendus Capital, the investment banking arm, is consistently ranked among the top investment banks in the country
on the back of its in-depth domain understanding and a best in the class track record of domestic and cross-border
transactions. Avendus’ wide range of clients is testimony to its ability to serve its corporates throughout their life cycle
– from growth stage funding to large-sized transactions, and M&A advisory.
Avendus Capital Inc located in New York is an Avendus Group entity offering M&A and Private Equity syndication
services to clients in the US.
For more information, please visit www.avendus.com.